ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 580,03
-0,69%
Dow Jones
40 809,95
1,49%
DAX
18 518,03
-0,44%
Brent Oil
83,325
-1,20%
Bitcoin
64 394,71
-0,70%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Allos Therapeutics, Inc. (MM) (ALTH)

  7. Allos Therapeutics, Inc. (MM) (ALTH) Actualités

ALTH

Allos Therapeutics, Inc. (MM) (ALTH)

Allos Therapeutics, Inc. (MM)
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:ALTH
DateHeureSourceTitreSymboleSociété
20/07/201118h16Business WireHarwood Feffer LLP Announces Investigation of Allos Therapeutics, Inc.NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
20/07/201116h37Business WireFaruqi & Faruqi, LLP Announces Investigation of Allos Therapeutics, Inc.NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
20/07/201116h37Business WireKendall Law Group Investigates Allos Therapeutics, Inc.NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
20/07/201114h01Edgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
20/07/201113h54Edgar (US Regulatory)Current report filing (8-K)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
20/07/201113h00Business WireAMAG Pharmaceuticals and Allos Therapeutics Agree to Merge to Strengthen Commercial Portfolio and Achieve Cost SynergiesNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
13/07/201122h21Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
20/06/201115h30ZacksLabel Expansion for CELG's Istodax - Analyst BlogNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
17/06/201123h29Business WireData Shows Activity of FOLOTYN® in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma Following Treatment with ...NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
17/06/201115h00MarketwiredResearch Report on Allos Therapeutics, Inc. and Spectrum Pharmaceuticals, Inc. -- BioPharm Looks Forward for GrowthNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
17/06/201112h50GlobeNewswire Inc.Allos Therapeutics is MicroStockProfit.com's Biopharm Feature StockNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
17/06/201108h30Business WireData Suggests Treatment with FOLOTYN® Reverses Trend of Progressive Resistance Observed in Patients with Drug-Resistant Rela...NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
16/06/201108h30Business WireCOMPLETE Registry Provides First Glance into Treatment Patterns for Patients with Peripheral T-Cell LymphomaNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
08/06/201115h00Business WireFOLOTYN® Data to be Presented at the Congress of the European Hematology Association & the International Conference on Malig...NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
06/06/201121h57Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
20/05/201118h49ZacksRisk-Reward Balanced at Allos - Analyst BlogNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
13/05/201118h55Zacks1Q Loss Narrows at Allos - Analyst BlogNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
10/05/201123h24Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
10/05/201122h05Business WireAllos Therapeutics and Mundipharma Announce Strategic Collaboration for FOLOTYNNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
10/05/201122h00Business WireAllos Therapeutics Reports First Quarter 2011 Financial ResultsNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
06/05/201120h42ZacksMixed Results for CELG's Revlimid - Analyst BlogNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
04/05/201114h00Business WireAllos Therapeutics to Present at Upcoming Investor Conferences in MayNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
03/05/201114h00Business WireAllos Therapeutics to Report First Quarter 2011 Results on May 10, 2011NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
02/05/201114h16MarketwiredOncology Drug Makers Positioned for Long Term GrowthNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
29/04/201118h35Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (DEFA14A)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
29/04/201118h31Edgar (US Regulatory)Proxy Statement (definitive) (DEF 14A)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
05/04/201119h01ZacksAllos Therapeutics at Neutral - Analyst BlogNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
04/04/201117h20ZacksCancer Study to Continue at SPPI - Analyst BlogNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
30/03/201114h00Business WireAllos Therapeutics to Present at Upcoming Investor ConferencesNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
17/03/201112h35MarketwiredSpeculative Biotech Firms Remain Popular Takeover TargetsNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
 Showing the most relevant articles for your search:NASDAQ:ALTH

Dernières Valeurs Consultées

EU
GLE
Societe Generale
FTSE
UKX
FTSE 100
EU
AI
Air Liquide
EU
PX1
CAC 40
EU
CAP
Capgemini
EU
VK
Vallourec
EU
BN
Danone
EU
BNP
BNP Paribas
EU
DG
Vinci
EU
MC
Lvmh Moet Hennessy Louis...
EU
ORA
Orange
COIN
BTCUSD
Bitcoin
SPI
SP500
S&P 500
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés